A Los Angeles jury has awarded $40 million to two women who claim Johnson & Johnson’s talcum powder caused their ovarian ...

A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson caused ...

These Institutional Investors Are Raising Their Stakes in Johnson & Johnson Stock. Should You Do the Same? They might be on ...

A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s baby powder was to blame for their ovarian cancer.

The trial featured two California women who developed ovarian cancer after decades of using the company's talc-based baby powder products. The award to plaintiffs Monica Kent and Deborah Schultz, and ...

The overlap between the work of J&J and Watts has led to a joint push to get women over 40 to focus on eye health. Together, ...

It is that time of the fantasy season where we do not keep up with the Jones' but the Johnson's instead. Here is the latest ...

Johnson & Johnson MedTech (NYSE:JNJ) is enacting an organizational restructuring, changing the way its business units operate ...

A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial alleging its talc products cause ...

Johnson & Johnson was ordered to pay $966 million to the family of a woman who alleged the New Brunswick-headquartered health giant’s talcum-based baby powder gave her a fatal cancer. Following a ...

Johnson & Johnson stock nears $200 after rally. Find out why analysts maintain a Hold rating on JNJ stock and a $220 price ...

A Los Angeles jury has awarded $40 million to two women who claim Johnson & Johnson's talcum powder caused their ovarian ...